Patients with inflammatory bowel disease (IBD) are at significantly higher risk of colon cancer compared to the general population[1]. A 2023 study confirmed that patients with IBD have an almost 600 percent higher risk of early colorectal cancer[1]. Long-term uncontrolled inflammation in the intestines, which characterizes both forms of IBD - Crohn's disease and ulcerative colitis - is a key mechanism that triggers the tumor process[1][3]. The risk of colon cancer increases with the duration of the disease, early onset of the disease and if there is a positive family history of colorectal cancer[3]. According to a 2024 survey, one in seven adults with IBD was only diagnosed after emergency admission to hospital due to the severity of symptoms[1]. Experts emphasize that early recognition of inflammatory bowel diseases and their consistent treatment is one of the most effective tools to stop the growing number of bowel cancer cases in young people[1].